Literature DB >> 15262238

Positron emission tomography and gene therapy: basic concepts and experimental approaches for in vivo gene expression imaging.

Iván Peñuelas1, JoséF Boán, Josep M Martí-Climent, Bruno Sangro, Guillermo Mazzolini, Jesús Prieto, José A Richter.   

Abstract

More than two decades of intense research have allowed gene therapy to move from the laboratory to the clinical setting, where its use for the treatment of human pathologies has been considerably increased in the last years. However, many crucial questions remain to be solved in this challenging field. In vivo imaging with positron emission tomography (PET) by combination of the appropriate PET reporter gene and PET reporter probe could provide invaluable qualitative and quantitative information to answer multiple unsolved questions about gene therapy. PET imaging could be used to define parameters not available by other techniques that are of substantial interest not only for the proper understanding of the gene therapy process, but also for its future development and clinical application in humans. This review focuses on the molecular biology basis of gene therapy and molecular imaging, describing the fundamentals of in vivo gene expression imaging by PET, and the application of PET to gene therapy, as a technology that can be used in many different ways. It could be applied to avoid invasive procedures for gene therapy monitoring; accurately diagnose the pathology for better planning of the most adequate therapeutic approach; as treatment evaluation to image the functional effects of gene therapy at the biochemical level; as a quantitative noninvasive way to monitor the location, magnitude and persistence of gene expression over time; and would also help to a better understanding of vector biology and pharmacology devoted to the development of safer and more efficient vectors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15262238     DOI: 10.1016/j.mibio.2004.04.004

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  7 in total

1.  Synthesis of 5-fluoroalkylated pyrimidine nucleosides via Negishi cross-coupling.

Authors:  Ann-Marie Chacko; Wenchao Qu; Hank F Kung
Journal:  J Org Chem       Date:  2008-06-04       Impact factor: 4.354

2.  Basic evaluation of FES-hERL PET tracer-reporter gene system for in vivo monitoring of adenoviral-mediated gene therapy.

Authors:  Talakad Goolaiah Lohith; Takako Furukawa; Tetsuya Mori; Masato Kobayashi; Yasuhisa Fujibayashi
Journal:  Mol Imaging Biol       Date:  2008-06-12       Impact factor: 3.488

Review 3.  Advances in transition metal (Pd, Ni, Fe)-catalyzed cross-coupling reactions using alkyl-organometallics as reaction partners.

Authors:  Ranjan Jana; Tejas P Pathak; Matthew S Sigman
Journal:  Chem Rev       Date:  2011-02-14       Impact factor: 60.622

Review 4.  Gene therapy imaging in patients for oncological applications.

Authors:  Iván Peñuelas; Uwe Haberkorn; Shahriar Yaghoubi; Sanjiv S Gambhir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

5.  A novel adenoviral vector labeled with superparamagnetic iron oxide nanoparticles for real-time tracking of viral delivery.

Authors:  Jonathan Yun; Adam M Sonabend; Ilya V Ulasov; Dong-Hyun Kim; Elena A Rozhkova; Valentyn Novosad; Stephen Dashnaw; Truman Brown; Peter Canoll; Jeffrey N Bruce; Maciej S Lesniak
Journal:  J Clin Neurosci       Date:  2012-04-18       Impact factor: 1.961

Review 6.  Use of radionuclides in cancer research and treatment.

Authors:  M T Macías
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

7.  PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine- and acycloguanosine-based radiotracers.

Authors:  Yury Likar; Konstantin Dobrenkov; Malgorzata Olszewska; Larissa Shenker; Shangde Cai; Hedvig Hricak; Vladimir Ponomarev
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-04       Impact factor: 9.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.